Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Matzkin

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Urology|June 1, 1992
In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell linesH Matzkin, M C Rangel, M S Soloway
Israel Journal of Medical Sciences|July 1, 1989
Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experienceH Matzkin, A Greenstein, I Kaver, et al.
Military Medicine|April 1, 1985
Tetanus immune status in reservists of the Israel Defence ForceH Matzkin, I Davidson, D Malovizky, et al.
The Journal of Infection|July 1, 1985
A study of the factors influencing tetanus immunity in Israeli male adultsH Matzkin, S Regev, R Kedem, et al.
Journal of Pineal Research|May 26, 1999
Melatonin receptors in PC3 human prostate tumor cellsE Gilad, M Laufer, H Matzkin, et al.
Cancer|April 1, 1989
Changes in prostate-specific markers under chronic gonadotrophin-releasing hormone analogue treatment of state D prostatic cancerH Matzkin, O Lewyshon, D Ayalon, et al.
Urology|November 1, 1989
Von Hippel-Lindau syndrome with unusual presentations in two brothersR Saranga, H Matzkin, J Papo, et al.
The Journal of Urology|February 1, 1991
Treatment of benign prostatic hypertrophy by a long-acting gonadotropin-releasing hormone analogue: 1-year experienceH Matzkin, J Chen, O Lewysohn, et al.
Urology|February 1, 1993
Relapse on endocrine treatment in patients with stage D2 prostate cancer. Does second-line hormonal therapy affect survival?H Matzkin, M C Rangel, M S Soloway
BJU International|September 1, 1999
Elevated urinary fibronectin levels after transurethral resection of bladder tumour: a possible role in patients failing therapy with bacillus Calmette-GuérinM Laufer, I Kaver, B Sela, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Urology|June 1, 1992
In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell linesH Matzkin, M C Rangel, M S Soloway
Israel Journal of Medical Sciences|July 1, 1989
Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experienceH Matzkin, A Greenstein, I Kaver, et al.
Military Medicine|April 1, 1985
Tetanus immune status in reservists of the Israel Defence ForceH Matzkin, I Davidson, D Malovizky, et al.
The Journal of Infection|July 1, 1985
A study of the factors influencing tetanus immunity in Israeli male adultsH Matzkin, S Regev, R Kedem, et al.
Journal of Pineal Research|May 26, 1999
Melatonin receptors in PC3 human prostate tumor cellsE Gilad, M Laufer, H Matzkin, et al.
Cancer|April 1, 1989
Changes in prostate-specific markers under chronic gonadotrophin-releasing hormone analogue treatment of state D prostatic cancerH Matzkin, O Lewyshon, D Ayalon, et al.
Urology|November 1, 1989
Von Hippel-Lindau syndrome with unusual presentations in two brothersR Saranga, H Matzkin, J Papo, et al.
The Journal of Urology|February 1, 1991
Treatment of benign prostatic hypertrophy by a long-acting gonadotropin-releasing hormone analogue: 1-year experienceH Matzkin, J Chen, O Lewysohn, et al.
Urology|February 1, 1993
Relapse on endocrine treatment in patients with stage D2 prostate cancer. Does second-line hormonal therapy affect survival?H Matzkin, M C Rangel, M S Soloway
BJU International|September 1, 1999
Elevated urinary fibronectin levels after transurethral resection of bladder tumour: a possible role in patients failing therapy with bacillus Calmette-GuérinM Laufer, I Kaver, B Sela, et al.
Pageof 11